Our Mission Statement

The International Castlemans Disease Organization is a non-profit institution committed to promoting the health of patients through advocacy, education, leadership, research, and service. This advocacy commitment is conducted through patient referrals to quality 'centers of excellence' where healthcare professionals and scientists research this rare disease for a comprehensive healthcare / treatment program.
ICDO Summit 2009 PDF Print E-mail
Written by Tony Howard   
Friday, 20 November 2009 18:06

ICDO hosted a one-day summit on Wednesday, December 2, 2009 in New Orleans.

 

ICDO hosted a one-day summit on Wednesday, December 2, in New Orleans, ahead of the 51st American Society of Hematology (ASH) Annual Meeting. Sponsored by Johnson & Johnson Pharmaceutical, Research & Development, LLC and OrthoBiotech, the summit was intended to foster awareness and understanding of Castleman's Disease (CD), a rare disorder characterized by non-cancerous growths that develop in the lymph node tissue at a single site or throughout the body. An international panel of medical experts discussed diagnosis and treatment options and several patients provided their perspective on living with the disease.

For those unable to attend, the summit will be videotaped with excerpts posted on the ICDO web site (www.castlemans.org) for the benefit of patients, caregivers and the medical community. Please direct questions to Jim Johnston, ICDO Founder, Executive Director, and Patient Advocate at  This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

 
Last Updated on Thursday, 25 February 2010 19:08